Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 22, 2024 06:55 ET | Source: ANTION BIOSCIENCES SA

Antion Biosciences announces development of safety-enhanced and off-the-shelf CAR T-cells for autoimmune disease

Aiming for a best-in-class solution to treat and cure B-cell driven autoimmune diseases
March 06, 2024 06:55 ET | Source: ANTION BIOSCIENCES SA

Antion Biosciences announces latest data and validation of its technology platform through important milestone achievements

Antion Biosciences release in vivo proof-of-concept data for miCAR7 and milestone achievement for Allogene Therapeutics
October 17, 2023 06:55 ET | Source: ANTION BIOSCIENCES SA

Antion Biosciences Announces Presentation of Two Abstracts from its Multiplex Cell Engineering Platform at the European Society of Gene and Cell Therapy (ESGCT) Annual Meeting

Functional demonstration of Antion’s uniquely capable technology to develop allogeneic anti-CD19 CAR T-cells with “tuned” silencing of HLA-I Latest advancements in the application of Antion’s miCAR...
September 06, 2023 09:23 ET | Source: ANTION BIOSCIENCES SA

Antion Announces Granting of Key Technology Patent in the United States

GENEVA, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Antion Biosciences SA (Antion), an innovative developer of cell and gene therapy technologies, is pleased to announce the granting of a significant patent...
August 09, 2023 06:55 ET | Source: ANTION BIOSCIENCES SA

Antion Welcomes John Tchelingerian as Chairman of the Board

GENEVA, Aug. 09, 2023 (GLOBE NEWSWIRE) -- Antion Biosciences SA (Antion) proudly announces the appointment of John Tchelingerian, PhD, a veteran of the biotech industry, as the new Chairman of its...